AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
NorthStar Medical Radioisotopes and YAP Therapeutics Enter Into Collaboration Agreement for Radiopharmaceutical Product Development
Jan 08, 2025•over 1 year ago
Contract Type
agreement
BiotechnologyHealth Care
Description
NorthStar Medical Radioisotopes, LLC and YAP Therapeutics, Inc. have entered into a collaboration agreement to develop and produce radiopharmaceuticals aimed at treating cancer and other chronic diseases. Within this collaboration, NorthStar will support the development of YAP Therapeutics' biologic products by supplying the radioisotope non-carrier added actinium-225 (n.c.a. Ac-225) and providing access to its radiopharmaceutical contract development and manufacturing (CDMO) services.
Company Information
Company
NorthStar Medical Radioisotopes and YAP Therapeutics
About
NorthStar Medical Radioisotopes, LLC is involved in the development, production, and commercialization of radiopharmaceuticals for therapeutic applications and medical imaging. YAP Therapeutics, Inc., a Fjord Ventures company, utilizes its advanced biologic and regenerative medicine technology platforms to develop treatments for chronic diseases.
Predictive Intelligence
Strategic
ML-powered predictions for NorthStar Medical Radioisotopes and YAP Therapeutics's next move
